The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


RAPYDAN

70/70 Milligram Medicated Plaster

Eurocept International BVPA1591/001/001

Main Information

Trade NameRAPYDAN
Active SubstancesLIDOCAINE
TETRACAINE
Strength70/70 Milligram
Dosage FormMedicated Plaster
Licence HolderEurocept International BV
Licence NumberPA1591/001/001

Group Information

ATC CodeN01BB52 lidocaine, combinations

Status

Authorised/WithdrawnAuthorised
Licence Issued25/01/2008
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot Marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back